KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Emergent BioSolutions (EBS) Long-Term Debt Repayments: 2010-2021

Historic Long-Term Debt Repayments for Emergent BioSolutions (EBS) over the last 3 years, with Mar 2021 value amounting to $10.6 million.

  • Emergent BioSolutions' Long-Term Debt Repayments was N/A to $10.6 million in Q1 2021 from the same period last year, while for Mar 2021 it was $152.0 million, marking a year-over-year change of. This contributed to the annual value of $10.6 million for FY2021, which is N/A change from last year.
  • Per Emergent BioSolutions' latest filing, its Long-Term Debt Repayments stood at $10.6 million for Q1 2021, which was down 47.00% from $20.0 million recorded in Q1 2017.
  • In the past 5 years, Emergent BioSolutions' Long-Term Debt Repayments ranged from a high of $20.0 million in Q1 2017 and a low of $10.6 million during Q1 2021.
  • Its 1-year average for Long-Term Debt Repayments is $10.6 million, with a median of $10.6 million in 2021.